| 1 |
33579790 |
10.1136/gutjnl-2020-322935 |
2022 |
Oncogenetic landscape of lymphomagenesis in coeliac disease. |
DDX3X |
| 2 |
35726023 |
10.1038/s41684-022-00998-x |
2022 |
The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications. |
DDX3X |
| 3 |
35794096 |
10.1038/s41467-022-31355-8 |
2022 |
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. |
DDX3X |
| 4 |
35815807 |
10.1158/0008-5472.CAN-21-2454 |
2022 |
The X-Linked Helicase DDX3X Is Required for Lymphoid Differentiation and MYC-Driven Lymphomagenesis. |
DDX3X |
| 5 |
35882439 |
10.1182/bloodadvances.2022007541 |
2022 |
Genetic and immunohistochemical profiling of NK/T-cell Lymphomas reveals prognostically relevant BCOR-MYC association. |
DDX3X |
| 6 |
36000950 |
10.1002/pbc.29926 |
2022 |
Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma. |
DDX3X |
| 7 |
32732362 |
10.3324/haematol.2020.254276 |
2021 |
Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1. |
DDX3X |
| 8 |
33808787 |
10.3390/cancers13061414 |
2021 |
EBV and the Pathogenesis of NK/T Cell Lymphoma. |
DDX3X |
| 9 |
34437837 |
10.1016/j.molcel.2021.07.041 |
2021 |
Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis. |
DDX3X |
| 10 |
34624215 |
10.1016/j.molcel.2021.09.009 |
2021 |
Sex, life, and death in MYC-driven lymphomagenesis. |
DDX3X |
| 11 |
34654425 |
10.1186/s12943-021-01437-0 |
2021 |
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes. |
DDX3X |
| 12 |
31738823 |
10.1182/blood.2019002699 |
2020 |
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. |
DDX3X |
| 13 |
31822801 |
10.1038/s41379-019-0415-5 |
2020 |
Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America. |
DDX3X |
| 14 |
32363958 |
10.1177/0300060520918087 |
2020 |
CD56-positive diffuse large B-cell lymphoma/leukemia with <i>BCL6/MYC</i> double-hit and multiple gene mutations: an indicator of poor prognosis? |
DDX3X |
| 15 |
32843425 |
10.1101/mcs.a004994 |
2020 |
Failure of tofacitinib to achieve an objective response in a <i>DDX3X-MLLT10</i> T-lymphoblastic leukemia with activating <i>JAK3</i> mutations. |
DDX3X |
| 16 |
33376237 |
10.1038/s41392-020-00331-3 |
2020 |
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma. |
DDX3X |
| 17 |
30563911 |
10.1101/gr.241141.118 |
2019 |
Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. |
DDX3X |
| 18 |
30664667 |
10.1038/s41564-018-0334-0 |
2019 |
Defective Epstein-Barr virus in chronic active infection and haematological malignancy. |
DDX3X |
| 19 |
30733272 |
10.3324/haematol.2018.207928 |
2019 |
Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. |
DDX3X |
| 20 |
31123138 |
10.1136/jclinpath-2019-205727 |
2019 |
Intravascular NK/T-cell lymphoma: clinicopathological and integrated molecular analysis of two cases provides a clue to disease pathogenesis. |
DDX3X |
| 21 |
31300419 |
10.1182/bloodadvances.2018029546 |
2019 |
Sporadic and endemic Burkitt lymphoma have frequent <i>FOXO1</i> mutations but distinct hotspots in the AKT recognition motif. |
DDX3X |
| 22 |
31305266 |
10.1097/PAS.0000000000001324 |
2019 |
Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin Lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With Hodgkin/Reed-Sternberg-like Cells of NK Phenotype. |
DDX3X |
| 23 |
31311407 |
10.1080/15384047.2019.1638670 |
2019 |
Somatic mutations in <i>KMT2D</i> and <i>TET2</i> associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders. |
DDX3X |
| 24 |
31391454 |
10.1038/s41419-019-1825-5 |
2019 |
Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3. |
DDX3X |
| 25 |
29674644 |
10.1038/s41467-018-03987-2 |
2018 |
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target. |
DDX3X |
| 26 |
29896680 |
10.1007/978-981-10-7230-7_21 |
2018 |
EBV in T-/NK-Cell Tumorigenesis. |
DDX3X |
| 27 |
30134235 |
10.1159/000492835 |
2018 |
Frequent Mutations in Natural Killer/T Cell Lymphoma. |
DDX3X |
| 28 |
30209976 |
10.1080/15384101.2018.1522912 |
2018 |
PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. |
DDX3X |
| 29 |
28033648 |
10.1002/gcc.22439 |
2017 |
Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia. |
DDX3X |
| 30 |
29375552 |
10.3389/fimmu.2017.01867 |
2017 |
Chronic Active Epstein-Barr Virus Disease. |
DDX3X |
| 31 |
26773734 |
10.1002/gcc.22348 |
2016 |
Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type. |
DDX3X |
| 32 |
25466511 |
10.1016/j.ejca.2014.10.017 |
2015 |
Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma. |
DDX3X |
| 33 |
26192917 |
10.1038/ng.3358 |
2015 |
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma. |
DDX3X |
| 34 |
24584351 |
10.3324/haematol.2013.101725 |
2014 |
DDX3X-MLLT10 fusion in adults with NOTCH1 positive T-cell acute lymphoblastic leukemia. |
DDX3X |
| 35 |
23673860 |
10.1182/blood-2013-02-487256 |
2013 |
New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia. |
DDX3X |
| 36 |
14729942 |
10.1074/mcp.D300003-MCP200 |
2004 |
Identification of phosphoproteins and their phosphorylation sites in the WEHI-231 B lymphoma cell line. |
DDX3X |
Datasets
Models
